GENinCode plc (AIM: GENI.L), a genetics company focused on the prevention of cardiovascular disease (“CVD”) and the early detection of ovarian cancer, announced on 14 February 2025 the launch of a fundraising comprising a
RNS Hotlist with Zak Mir: JLP, BANK, BRES, GENI, WG, SENX, PPS, TLY, TRT, CMET, GWMO & POW
Jubilee (JLP), a diversified metals producer with operations in South Africa and Zambia, announced an operational update at its Zambian copper business. Further to the announcement of 6 February 2025, the
Share Talk Weekly Stock Market News Review, Sunday 26th January 2025
The blue-chip FTSE 100 slipped by 0.7%, yet it remained on track to achieve its fifth consecutive week of gains. This week saw the benchmark reach an all-time high, buoyed
GENinCode PLC (AIM:GENI) CARDIO inCode Lab Fee Update & Catalonia Launch
CARDIO inCode® inclusion in the US CMS 2025 Clinical Lab Fee Schedule and launch in the Spanish region of Catalonia
GENinCode PLC (AIM:GENI) Partnership with Genesupport SA for the ROCA® Test
GENinCode partners with Genesupport SA for the ROCA® Test in Switzerland Ovarian cancer surveillance using the ROCA Test to be made available to individuals across Switzerland
RNS Hotlist with Zak Mir: VOD, BOWL, SOND, CHLL, INC, HVO, POW, GENI, HERC & SVML
The Daily Telegraph reported that China founded, Singapore based fashion giant Shein is to list in London.
Share Talk Weekly Stock Market News Review, Sunday 3rd December 2023
Data from the London Stock Exchange Group PLC (LSE: LSEG) reveals that trading volumes up to October 2023 have decreased by 22% year-to-date, accompanied by a 37% reduction in the number of
RNS Hotlist with Zak Mir: EEE, GENI, 88E, ARV, AURA, ARK, LIFS, GST, MSMN, SNX, AQX & AXL
Empire Metals (EEE), the AIM-quoted resource exploration and development company, announced the analytical lab results from the second and third diamond core drillholes completed at the Pitfield Project in Western Australia,